本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

14.95
-0.2600-1.71%
盤後14.950.00000.00%19:30 EDT
成交量:213.85萬
成交額:3,198.59萬
市值:21.23億
市盈率:-42.50
高:15.38
開:15.17
低:14.81
收:15.21
52周最高:20.22
52周最低:8.04
股本:1.42億
流通股本:1.18億
量比:1.13
換手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.60
市盈率(LYR):-47.11

資料載入中...

2022/05/16

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/07

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

重要事件披露

8-K - Current report